BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11160182)

  • 1. The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1.
    Le Y; Yazawa H; Gong W; Yu Z; Ferrans VJ; Murphy PM; Wang JM
    J Immunol; 2001 Feb; 166(3):1448-51. PubMed ID: 11160182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.
    Resnati M; Pallavicini I; Wang JM; Oppenheim J; Serhan CN; Romano M; Blasi F
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1359-64. PubMed ID: 11818541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors.
    Su SB; Gao Jl; Gong Wh; Dunlop NM; Murphy PM; Oppenheim JJ; Wang JM
    J Immunol; 1999 May; 162(10):5924-30. PubMed ID: 10229829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages.
    Yang D; Chen Q; Le Y; Wang JM; Oppenheim JJ
    J Immunol; 2001 Mar; 166(6):4092-8. PubMed ID: 11238658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.
    Le Y; Gong W; Li B; Dunlop NM; Shen W; Su SB; Ye RD; Wang JM
    J Immunol; 1999 Dec; 163(12):6777-84. PubMed ID: 10586077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells.
    Su SB; Gong W; Gao JL; Shen W; Murphy PM; Oppenheim JJ; Wang JM
    J Exp Med; 1999 Jan; 189(2):395-402. PubMed ID: 9892621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1.
    Le Y; Gong W; Tiffany HL; Tumanov A; Nedospasov S; Shen W; Dunlop NM; Gao JL; Murphy PM; Oppenheim JJ; Wang JM
    J Neurosci; 2001 Jan; 21(2):RC123. PubMed ID: 11160457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines.
    Shen W; Proost P; Li B; Gong W; Le Y; Sargeant R; Murphy PM; Van Damme J; Wang JM
    Biochem Biophys Res Commun; 2000 May; 272(1):276-83. PubMed ID: 10872839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1.
    Hu JY; Le Y; Gong W; Dunlop NM; Gao JL; Murphy PM; Wang JM
    J Leukoc Biol; 2001 Jul; 70(1):155-61. PubMed ID: 11435499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and function of formyl peptide receptors on human fibroblast cells.
    VanCompernolle SE; Clark KL; Rummel KA; Todd SC
    J Immunol; 2003 Aug; 171(4):2050-6. PubMed ID: 12902510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages.
    Yazawa H; Yu ZX; Takeda ; Le Y; Gong W; Ferrans VJ; Oppenheim JJ; Li CC; Wang JM
    FASEB J; 2001 Nov; 15(13):2454-62. PubMed ID: 11689470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
    He R; Tan L; Browning DD; Wang JM; Ye RD
    J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential roles of the NPXXY motif in formyl peptide receptor signaling.
    He R; Browning DD; Ye RD
    J Immunol; 2001 Mar; 166(6):4099-105. PubMed ID: 11238659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells.
    Cui YH; Le Y; Gong W; Proost P; Van Damme J; Murphy WJ; Wang JM
    J Immunol; 2002 Jan; 168(1):434-42. PubMed ID: 11751990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family.
    Murphy PM; Ozçelik T; Kenney RT; Tiffany HL; McDermott D; Francke U
    J Biol Chem; 1992 Apr; 267(11):7637-43. PubMed ID: 1373134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2.
    Christophe T; Karlsson A; Dugave C; Rabiet MJ; Boulay F; Dahlgren C
    J Biol Chem; 2001 Jun; 276(24):21585-93. PubMed ID: 11285256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for chemotactic formyl peptides as pharmacological targets.
    Le Y; Yang Y; Cui Y; Yazawa H; Gong W; Qiu C; Wang JM
    Int Immunopharmacol; 2002 Jan; 2(1):1-13. PubMed ID: 11789660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple activation steps of the N-formyl peptide receptor.
    Prossnitz ER; Gilbert TL; Chiang S; Campbell JJ; Qin S; Newman W; Sklar LA; Ye RD
    Biochemistry; 1999 Feb; 38(8):2240-7. PubMed ID: 10029516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of functional formyl peptide receptors by human astrocytoma cell lines.
    Le Y; Hu J; Gong W; Shen W; Li B; Dunlop NM; Halverson DO; Blair DG; Wang JM
    J Neuroimmunol; 2000 Nov; 111(1-2):102-8. PubMed ID: 11063827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of formyl peptide receptor signaling by peptide ligands.
    Bae YS; Song JY; Kim Y; He R; Ye RD; Kwak JY; Suh PG; Ryu SH
    Mol Pharmacol; 2003 Oct; 64(4):841-7. PubMed ID: 14500740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.